World News Today: New neuroimaging marker may identify persons at risk of dementia in future clinical trials
Posted on: Friday, November 22nd, 2024
Claudia Satizábal, PhD, associate professor at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio; Sudha Seshadri, MD, director of the Biggs Institute;
and director of the Biggs Institute and co-author of the study; and Alison Luckey, PhD, postdoctoral research fellow at the Biggs Institute discuss a landmark UT Health San Antonio-led study that discovered a new neuroimaging marker of cerebral small vessel disease that could be used for future dementia trials.
Read the article at WorldNewsToday.com.